| __timestamp | Novavax, Inc. | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 19928000 | 13774000 |
| Thursday, January 1, 2015 | 30842000 | 22479000 |
| Friday, January 1, 2016 | 46527000 | 27388000 |
| Sunday, January 1, 2017 | 34451000 | 35610000 |
| Monday, January 1, 2018 | 34409000 | 49007000 |
| Tuesday, January 1, 2019 | 34417000 | 61139000 |
| Wednesday, January 1, 2020 | 145290000 | 68836000 |
| Friday, January 1, 2021 | 298358000 | 97592000 |
| Saturday, January 1, 2022 | 488691000 | 106903000 |
| Sunday, January 1, 2023 | 468946000 | 120998000 |
Unleashing the power of data
In the competitive landscape of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. From 2014 to 2023, Vericel Corporation and Novavax, Inc. have shown contrasting approaches to SG&A cost management. Vericel's SG&A expenses grew steadily, peaking at approximately $121 million in 2023, marking a 780% increase from 2014. In contrast, Novavax's expenses surged dramatically, reaching nearly $469 million in 2023, a staggering 2,255% rise from 2014. This disparity highlights Novavax's aggressive expansion strategy, while Vericel maintained a more controlled growth. The data suggests that Vericel's approach may offer more sustainable cost management, potentially providing a competitive edge in the long run. Investors and industry analysts should consider these trends when evaluating the financial strategies of these biotech firms.
Eli Lilly and Company and Novavax, Inc.: SG&A Spending Patterns Compared
BeiGene, Ltd. vs Vericel Corporation: SG&A Expense Trends
Neurocrine Biosciences, Inc. and Vericel Corporation: SG&A Spending Patterns Compared
Comparing SG&A Expenses: BioMarin Pharmaceutical Inc. vs Novavax, Inc. Trends and Insights
Catalent, Inc. or Novavax, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Cytokinetics, Incorporated vs Vericel Corporation
Comparing SG&A Expenses: CymaBay Therapeutics, Inc. vs Novavax, Inc. Trends and Insights
Rhythm Pharmaceuticals, Inc. and Vericel Corporation: SG&A Spending Patterns Compared
Rhythm Pharmaceuticals, Inc. or Novavax, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Veracyte, Inc. and Vericel Corporation
Comparing SG&A Expenses: Vericel Corporation vs Merus N.V. Trends and Insights
Cost Management Insights: SG&A Expenses for Vericel Corporation and Supernus Pharmaceuticals, Inc.